Renal Medical Devices and Services Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Dialysis Equipment, Renal Denervation Devices, Wearable Artificial Kidney Device, Distal Embolic Protection Devices), Application (Kidney Failure, Chronic Kidney Disease, End-Stage Kidney Disease, Renal Kidney Stone Disease, Hypertension, Diabetes, Others), By Region, & Competition, 2020-2030F

Market Overview

Global Renal Medical Devices and Services Market was valued at USD 15.90 Billion in 2024 and is anticipated to witness an steady growth in the forecast period with a CAGR of 5.15% through 2030. Renal medical devices are specialized medical instruments, equipment, and devices designed to diagnose, treat, or manage conditions related to the kidneys and the urinary system. These devices play a critical role in the field of nephrology (the study of kidneys) and are used in various clinical settings, including hospitals, clinics, and home care. Renal medical devices encompass a wide range of technologies and tools aimed at addressing kidney-related issues. Various imaging devices, such as ultrasound machines, CT scanners, and MRI machines, are used to visualize the kidneys and diagnose kidney-related conditions, including tumors, cysts, and kidney stones. The increasing incidence of kidney diseases, including chronic kidney disease (CKD) and end-stage renal disease (ESRD), is a significant driver. Factors such as aging populations, diabetes, hypertension, and lifestyle-related health issues contribute to a growing patient pool in need of renal medical devices and services.

The global demographic shift toward an aging population has led to a higher prevalence of kidney-related issues. Older individuals are more susceptible to kidney disease, and this demographic trend is expected to continue driving demand for renal medical devices and services. Continuous innovation in renal medical devices, such as dialysis machines, monitoring equipment, and surgical instruments, drives market growth. Advancements improve treatment outcomes, patient comfort, and the efficiency of care delivery. Rising awareness among patients and healthcare providers about kidney diseases and the importance of early diagnosis and treatment encourages greater utilization of renal medical devices and services. Government initiatives aimed at improving healthcare infrastructure and access to renal care services can be a significant driver. Public health programs and insurance coverage often support the use of renal medical devices and services.

Key Market Drivers

Rising Prevalence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD)

The rising prevalence of chronic kidney disease (CKD) and End-Stage Renal Disease (ESRD) is one of the most significant drivers of growth in the Global Renal Medical Devices and Services Market. As the incidence of kidney diseases continues to increase globally, the demand for renal-related treatments, devices, and services is expanding. An estimated 700 million people globally are affected by Chronic Kidney Disease (CKD). When considering the additional burden of Acute Kidney Injury (AKI) and kidney failure, which includes individuals undergoing dialysis and those with kidney transplants, the global prevalence of kidney disease rises to approximately 850 million, representing more than 10% of the global population. It is important to note that this figure likely underrepresents the true scale of the problem. The lack of widespread early detection and screening programs in many regions leads to significant underreporting and unawareness of earlier stages of CKD, further exacerbating the challenge and obscuring the full extent of the global kidney disease burden.

Chronic Kidney Disease and its progression to End-Stage Renal Disease (ESRD) result in a critical need for continuous medical interventions, primarily dialysis and related therapies. As the number of CKD and ESRD patients rises, there is an increasing demand for dialysis machines, kidney monitors, filtration systems, and other essential renal devices. This demand directly fuels market growth, as healthcare providers require advanced and reliable technology to provide efficient treatment for patients at various stages of kidney failure. As more patients develop ESRD, the need for hemodialysis and peritoneal dialysis devices rises. These machines need to be more effective, efficient, and accessible to handle the growing patient load. Devices such as vascular access systems, dialyzers, and artificial kidneys are essential to treating ESRD patients. Their continued innovation and demand contribute to market expansion.

The rise in kidney diseases is heavily influenced by the increasing prevalence of risk factors like diabetes, hypertension, and obesity, all of which are linked to CKD. As lifestyle-related diseases continue to affect populations globally, the rates of CKD and ESRD are expected to continue increasing. According to health statistics, Diabetes is the leading cause of kidney disease, with hypertension and diabetes collectively responsible for driving 2 of 3 of all new cases of kidney failure. These conditions significantly contribute to the increasing global burden of renal disease, highlighting the urgent need for targeted interventions and management strategies. Healthcare systems worldwide are under pressure to provide more frequent and advanced renal services, leading to increased investments in dialysis centers, healthcare facilities, and home dialysis services. Early detection and management services are expanding as more people undergo kidney screenings, increasing the need for diagnostic tools, kidney function tests, and associated medical services.

Growing Aging Population

The aging population is one of the most significant drivers behind the growth of the Global Renal Medical Devices and Services Market. By 2050, 80% of the global elderly population will reside in low- and middle-income countries, a shift that underscores the rapid pace of population aging compared to previous decades. Notably, in 2020, the number of individuals aged 60 years and older surpassed the population of children under 5 years. From 2015 to 2050, the proportion of the global population aged over 60 will nearly double, increasing from 12% to 22%, presenting significant challenges and opportunities for healthcare systems, particularly in aging regions. As the global demographic shifts toward an older population, particularly in developed regions such as North America, Europe, and parts of Asia, the demand for healthcare services and medical devices, including those for renal care, is expanding. Chronic Kidney Disease (CKD) has become an established, progressive condition affecting over 10% of the global population, emerging as a leading cause of global mortality. Notably, the prevalence of CKD is markedly higher among the aging population, driving increased attention to the need for targeted healthcare solutions and interventions to manage the growing burden of this disease in older demographics.

As individuals age, their kidneys naturally experience a decline in function due to physiological changes, including reduced glomerular filtration rate (GFR), which is a key indicator of kidney function. The aging process often leads to a greater risk of developing Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD). The aging population is therefore more vulnerable to kidney-related issues, leading to a higher prevalence of kidney diseases and, consequently, an increased demand for renal medical devices and services. The elderly are more likely to require dialysis due to kidney dysfunction. As kidney failure progresses to ESRD, the need for dialysis machines (both hemodialysis and peritoneal dialysis) becomes crucial for survival. The aging population directly contributes to a higher need for these devices. Older adults who experience kidney failure often require kidney transplants, which drives demand for related medical devices such as transplant monitoring systems and organ preservation equipment. In 2023, kidneys represented the majority of organ transplants, accounting for 65% of all procedures. During the same year, 24% of transplants were for livers, and 6% were for hearts. A total of 111,135 kidney transplants were performed globally, highlighting the critical demand for renal transplant solutions in the healthcare sector.

Elderly individuals typically experience a higher incidence of multimorbidity—the presence of two or more chronic diseases. Kidney disease often coexists with other age-related conditions like hypertension, diabetes, and cardiovascular diseases. These comorbidities exacerbate the risk and progression of CKD, as conditions such as high blood pressure and uncontrolled diabetes are leading causes of kidney damage. As the number of elderly people with these conditions increases, the incidence of kidney disease also rises, driving the demand for renal devices and services. The need for integrated healthcare services that cater to elderly individuals with multiple chronic conditions is increasing. This includes the development of multidisciplinary renal care teams, which may require advanced diagnostic tools, remote monitoring devices, and patient management software. Multimorbidity increases the demand for tailored dialysis solutions that can cater to the specific needs of elderly patients, such as machines designed to accommodate other comorbidities or reduce the burden of dialysis sessions.

Download Free Sample Report

Key Market Challenges

Economic Uncertainty

Economic instability and uncertainty can affect various aspects of the market, including purchasing decisions, healthcare budgets, and investment in medical devices and services. During periods of economic uncertainty, healthcare facilities, including hospitals and clinics, may face budget constraints. This can lead to limitations on capital expenditures, including the acquisition of new renal medical devices or the expansion of renal care services. Economic uncertainty can make healthcare organizations cautious about making major investments. They may delay the purchase of new renal medical equipment or upgrades to existing devices, which can affect market demand. Economic challenges can result in pricing pressure for medical device manufacturers and service providers.

Healthcare facilities may seek cost-effective solutions and negotiate for lower prices, affecting profit margins in the industry. Economic uncertainty may lead to reduced funding for research and development initiatives aimed at developing new renal medical devices and services. This can slow down innovation in the field. Medical device companies may face challenges in securing financing for product development and expansion during periods of economic instability. This can hinder their ability to bring new products to the market. Economic uncertainty can contribute to market volatility, affecting the stock prices of medical device manufacturers and potentially reducing investor confidence in the sector. Economic uncertainty can influence patient behavior. Patients may postpone elective procedures or seek lower-cost alternatives for renal care, affecting the utilization of medical devices and services.

Environmental Sustainability

Dialysis and renal care generate a significant amount of medical waste, including used dialysis supplies, packaging materials, and disposable medical devices. Proper disposal and management of this waste to minimize environmental harm is a challenge. Dialysis machines and healthcare facilities in general consume a substantial amount of energy. Energy-efficient equipment and sustainable facility design are becoming important considerations to reduce the environmental footprint. Dialysis requires a substantial amount of water for the purification process. Efficient water usage and wastewater management are important for minimizing environmental impact, especially in regions with water scarcity.

Many renal medical devices and supplies are designed for single use to maintain sterility and reduce infection risk. However, this contributes to increased waste generation. Finding sustainable alternatives or recycling solutions for these products can be challenging. The use of chemical disinfectants in dialysis and renal care can have environmental implications. Proper disposal of these chemicals and the development of eco-friendly alternatives are important considerations. The production and distribution of renal medical devices and supplies can have a significant environmental impact. Companies are increasingly evaluating their supply chain practices reducing carbon emissions and minimizing environmental harm. Increasing the lifespan of medical devices and equipment can reduce waste generation. However, balancing product durability with the need for up-to-date technology and safety standards is a challenge.

Key Market Trends

Home Hemodialysis

Home hemodialysis refers to the provision of hemodialysis treatment for patients with end-stage renal disease (ESRD) in the comfort of their own homes. Many patients prefer home hemodialysis over in-center treatment because it offers greater flexibility and the ability to tailor treatment schedules to their daily lives. This preference for a more patient-centered approach has driven the demand for home hemodialysis devices and services. Home hemodialysis allows patients to have more control over their treatment, which can lead to an improved quality of life. Patients can dialyze more frequently or for longer durations, which may result in better clinical outcomes. Patients undergoing in-center hemodialysis often need to travel to a healthcare facility multiple times a week.

Home hemodialysis eliminates the need for such frequent travel, reducing the burden on patients and their families. Home hemodialysis can reduce a patient's exposure to infections and diseases commonly found in healthcare facilities, which is particularly important during the COVID-19 pandemic and for patients with compromised immune systems. Home hemodialysis can be cost-effective for both patients and healthcare systems. It reduces the cost of facility-based care, including overhead expenses associated with dialysis centers. Medical device manufacturers have developed more user-friendly and compact home hemodialysis machines. These devices are designed to be easy to use and maintain, making home treatment more accessible to a broader range of patients. Telehealth and remote monitoring technologies enable healthcare providers to monitor patients' progress and adjust treatment remotely, enhancing the safety and effectiveness of home hemodialysis.

Segmental Insights

Product Insights

In 2024, The Dialysis Equipment segment is the fastest-growing category within the Global Renal Medical Devices and Services Market, driven by multiple factors related to the increasing global burden of kidney diseases, particularly End-Stage Renal Disease (ESRD).  the key drivers behind the growth of the dialysis equipment segment is the steady rise in ESRD cases globally. As the prevalence of Chronic Kidney Disease (CKD) increases, a significant portion of these patients progress to ESRD, necessitating long-term dialysis treatments. With diabetes and hypertension being major risk factors, the number of people requiring dialysis is expected to continue to grow, thus boosting demand for hemodialysis and peritoneal dialysis equipment. Dialysis is a life-sustaining treatment for individuals with ESRD. As the patient pool expands, the need for advanced and efficient dialysis machines grows significantly. This includes both in-center and home dialysis solutions, which contribute to the overall market expansion.

Technological innovations in dialysis equipment are a key factor driving growth. Companies are increasingly investing in developing more efficient, user-friendly, and cost-effective dialysis machines. These devices are designed to improve patient outcomes by reducing treatment time, enhancing safety, and providing greater comfort during dialysis sessions. With the rise in home dialysis treatments, there is a growing demand for portable, automated dialysis machines that offer patients greater flexibility and the convenience of receiving treatment at home. These devices are designed to be easier to use, more compact, and adaptable to a broader range of patient needs, especially those in older age groups or with limited mobility. The integration of IoT (Internet of Things) capabilities and artificial intelligence into dialysis machines allows for real-time monitoring, remote patient management, and early detection of complications. This innovation not only improves the quality of care but also enhances operational efficiency, appealing to healthcare providers and patients alike.

Download Free Sample Report

Regional Insights

The North America region has the largest share in the Global Renal Medical Devices and Services Market in 2022. A well-developed and organized health care system, which promotes research and development, is one factor that is anticipated to contribute to the market's expansion. Global players are encouraged to enter the United States and Canada thanks to these R&D policies. These nations benefit from the presence of several international market players as a result. The market is anticipated to grow even more because of the region's global players' ability to meet the high and rising demand. The expansion of the market is also being aided by the increase in innovative renal problem treatments being researched and developed by various organizations in the US.

Recent Developments

• In January 2025, Medtronic plc announced that the Centers for Medicare & Medicaid Services (CMS) is initiating a national coverage analysis (NCA) to evaluate the potential inclusion of renal denervation procedures for patients with hypertension in the national Medicare coverage policy. This NCA was prompted by Medtronic's request, aiming to expand Medicare beneficiary access to the Symplicity Spyral renal denervation (RDN) system, which is used in the Symplicity blood pressure procedure. This move is expected to advance the availability of this innovative treatment for patients suffering from uncontrolled hypertension.
• In April 2023, the founding of Mozarc Medical, an independent new company dedicated to changing kidney health and advancing patient-centered technology solutions, was announced by Medtronic plc and DaVita Inc. Health care company DaVita is committed to modernising care delivery to raise patient quality of life across the globe. The business is a leader in clinical quality and innovation and one of the largest renal care service providers in the United States. DaVita provides care for patients at every stage and location of their path towards better kidney health, from halting the progression of kidney disease to supporting transplantation, from emergency hospital treatment to home dialysis.
• In February 2023, Rockwell Medical, Inc. (Nasdaq: RMTI), a commercial healthcare company specializing in life-sustaining treatments for patients with blood disorders and kidney-related diseases, has announced the signing of a three-year product purchase agreement with Concerto Renal Services, the leading provider of dialysis services in skilled nursing facilities across the United States. This partnership underscores Rockwell Medical’s commitment to expanding its presence in the renal care market and enhancing its product offerings to support the needs of dialysis patients in skilled nursing settings.
• In May 2022, to improve patient treatment experiences and general results, Medtronic pl and DaVita Inc. announced their intention to establish a new, independent medical device company ("NewCo" or "the Company") with a focus on renal care. NewCo will be ideally positioned to promote the development of innovative medicines for patients with kidney failure by combining Medtronic's skills as a healthcare technology leader and DaVita's significant expertise as a comprehensive renal care provider. The Company will concentrate on creating a broad range of innovative kidney care products and solutions, including upcoming home-based devices, to increase patient access to various dialysis treatments.
• In October 2021, The Paradise ultrasonic renal denervation system from ReCor Medical, Inc., a fully owned subsidiary of Otsuka Medical Devices Co., Ltd., has launched in Europe. Germany now offers the Paradise system for the treatment of uncontrolled hypertension. Heart Centre Leipzig in Leipzig, Germany, and Saarland University Hospital in Homburg/Saar, Germany, are the first facilities to offer the surgery commercially. The RADIANCE-HTN SOLO and TRIO trials of the Paradise system were studied by Professor Felix Mahfoud, MD, of Saarland University Hospital. Additionally, he is the director of the German Society of Cardiology's Arterial Hypertension Working Group.

Key Market Players

• Abbott Laboratories Inc.
• B Braun Melsungen AG
• Baxter International Inc
• Becton, Dickinson, and Company
• Boston Scientific Corporation
• DaVita Healthcare Partners, Inc
• Fresenius SE & Co. KGaA
• Infomed SA
• Medtronic Inc.
• Nipro Corporation

Report Scope:

In this report, the Global Renal Medical Devices and Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

•  Renal Medical Devices and Services Market, By Product:

o   Dialysis Equipment

o   Renal Denervation Devices

o   Wearable Artificial Kidney Device

o   Distal Embolic Protection Devices

•  Renal Medical Devices and Services Market, By Application:

o   Kidney Failure

o   Chronic Kidney Disease

o   End-stage kidney disease

o   Renal Kidney Stone Disease

o   Hypertension

o   Diabetes

o   Others

• Renal Medical Devices and Services Market, By region:

o   North America

§  United States

§  Canada

§  Mexico

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Australia

§  Japan

o   Europe

§  Germany

§  France

§  United Kingdom

§  Spain

§  Italy

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Renal Medical Devices and Services Market.

Available Customizations:

Global Renal Medical Devices and Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Renal Medical Devices and Services Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]